Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 25 peer-reviewed journal articles Updated
Genetics

The "Why": Causes and Genetic Testing in 46,XY DSD

At a Glance

46,XY DSD is caused by genetic variations that alter standard male physical development. These changes affect how the body forms testes, produces testosterone, or responds to hormones. Advanced genetic testing is the most accurate way to pinpoint the exact cause and guide long-term care.

While every person is unique, a diagnosis of 46,XY Difference of Sex Development (DSD) essentially means that the typical path from an XY chromosome to typical male development was altered by a specific genetic or hormonal change [1][2]. Understanding the “why” behind the diagnosis requires looking at the genes that act as the body’s instruction manual.

The Biological Mechanisms

For typical male development to occur, a series of precisely timed events must happen:

  1. Instruction: The SRY gene on the Y chromosome tells the early gonads to become testes [1].
  2. Formation: Other genes, like NR5A1, help build these testes and ensure they can produce hormones [3][4].
  3. Production: The testes produce testosterone, the primary male hormone [5].
  4. Conversion: An enzyme called 5-alpha reductase (encoded by the SRD5A2 gene) converts testosterone into a stronger hormone called DHT, which is responsible for shaping external male genitalia [6][7].
  5. Reception: The body uses androgen receptors (encoded by the AR gene) to “hear” and respond to these hormones [8][9].

In 46,XY DSD, one of these steps is bypassed or altered.

Major Subtypes of 46,XY DSD

Understanding the specific subtype is key to planning care.

Androgen Insensitivity Syndrome (AIS)

In AIS, the body produces testosterone, but the cells cannot fully respond to it because the androgen receptor (AR) is not working correctly [8][10].

  • Complete AIS (CAIS): The body is entirely “deaf” to male hormones. The individual typically has a female external appearance, but internally has testes and no uterus [11][12].
  • Partial AIS (PAIS): The body can respond to some male hormones but not all, leading to a wide range of physical appearances [10][13].

5-Alpha Reductase Deficiency

The body makes testosterone, but it cannot convert it into DHT (the “strong” testosterone) because of a change in the SRD5A2 gene [6]. Because DHT is needed for external male development, infants often have atypical or female-appearing genitalia at birth, but they may undergo significant masculinization during puberty when testosterone levels naturally spike [14][15].

Gonadal Dysgenesis (Swyer Syndrome)

In this condition, the early gonads do not develop into testes as expected, often because of variations in genes like SRY or NR5A1 [16][3]. Because the gonads do not produce the necessary hormones, the individual typically develops a female appearance and has a uterus, but they will not go through puberty without hormone support [16].

The Modern Diagnostic Standard

In the past, doctors relied almost entirely on biochemical panels (blood tests measuring hormone levels) to make a diagnosis. However, hormone levels can be misleading or overlap between different conditions [17].

Today, Next-Generation Sequencing (NGS) and Whole Exome Sequencing (WES) are the gold standards for diagnosis [18][19]. These advanced genetic tests scan hundreds or even thousands of genes simultaneously to find the exact variant in the DNA [20]. This provides a much more accurate diagnosis than blood tests alone and helps predict future health needs, such as tumor risks or fertility options [21][22].

Lab/Genetic Report Completeness Checklist

When reviewing genetic results, ensure the report includes these key elements:

  • Karyotype Confirmation: Clearly states “46,XY.”
  • Specific Gene Identified: (e.g., AR, SRD5A2, NR5A1, SRY).
  • Variant Classification: Uses standard terms like “Pathogenic” (causing the condition) or “Likely Pathogenic” [23].
  • Genotype-Phenotype Correlation: A section explaining how the genetic finding matches the physical features [23][24].
  • Zygosity: States whether the change was found on one or both copies of the gene. Note: Because 46,XY individuals only have one X chromosome, variants on X-linked genes (like the AR gene in AIS) are referred to as “Hemizygous.”
  • Müllerian Status: Mentions whether a uterus or fallopian tubes were seen on imaging, as this helps narrow down the cause [25].

Common questions in this guide

What causes 46,XY DSD?
46,XY DSD occurs when there is a specific genetic or hormonal change that alters the typical pathway of male physical development. These variations can affect the genes responsible for forming the testes, producing testosterone, or allowing the body's cells to respond to hormones.
What is Complete Androgen Insensitivity Syndrome (CAIS)?
In Complete AIS, the body produces testosterone, but the cells cannot respond to it at all due to a variation in the androgen receptor. This typically results in a female external appearance, but the individual has internal testes and no uterus.
How does 5-alpha reductase deficiency affect development?
This condition prevents the body from converting testosterone into a stronger hormone called DHT, which is needed for external male development. Infants may be born with atypical or female-appearing genitalia, but they can experience significant masculinization later during puberty.
Why is genetic testing better than blood tests for diagnosing DSD?
While hormone blood tests were commonly used in the past, they can sometimes be misleading. Modern genetic tests, like Whole Exome Sequencing, are much more accurate because they can find the exact DNA variant causing the condition and help predict future health needs.
What does a 'pathogenic' variant mean on my genetic report?
When a genetic test report classifies a variant as 'pathogenic' or 'likely pathogenic', it means that specific change in your DNA has been definitively identified as the cause of the condition.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Which specific gene variation was found, and is it classified as 'pathogenic' or a 'variant of uncertain significance' (VUS)?
  2. 2.How do these genetic results compare to the hormone levels, like the testosterone-to-DHT ratio?
  3. 3.Does this genetic diagnosis change our understanding of whether internal structures like a uterus or ovaries are present?
  4. 4.How does this specific genetic finding influence long-term health risks, such as the risk of gonadal tumors?
  5. 5.Is there a 'genotype-phenotype correlation' in the report that explains how this gene change relates to physical features?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (25)
  1. 1

    Clinical Spectrum, Surgical Management, and Outcomes of NR5A1-Related 46,XY Differences of Sex Development: A Narrative Review.

    Vicario S, Escolino M, Esposito G, et al.

    Medicina (Kaunas, Lithuania) 2025; (61(11)) doi:10.3390/medicina61111965.

    PMID: 41303802
  2. 2

    Genetic Variants in SRD5A2 in a Spectrum of DSD Patients from Australian Clinics Highlight Importance of Genetic Testing alongside Typical First-Line Investigations.

    Robevska G, Hanna C, van den Bergen J, et al.

    Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation 2023; (17(1)):8-15 doi:10.1159/000527754.

    PMID: 36724755
  3. 3

    Worldwide cohort study of 46, XY differences/disorders of sex development genetic diagnoses: geographic and ethnic differences in variants.

    Jiali C, Huifang P, Yuqing J, et al.

    Frontiers in genetics 2024; (15()):1387598 doi:10.3389/fgene.2024.1387598.

    PMID: 38915825
  4. 4

    Novel Genomic Variants, Atypical Phenotypes and Evidence of a Digenic/Oligogenic Contribution to Disorders/Differences of Sex Development in a Large North African Cohort.

    Zidoune H, Ladjouze A, Chellat-Rezgoune D, et al.

    Frontiers in genetics 2022; (13()):900574 doi:10.3389/fgene.2022.900574.

    PMID: 36110220
  5. 5

    Hormone replacement in disorders of sex development, and long-term effects.

    Nordenström A, Mangone A, Mantovani G

    Best practice & research. Clinical endocrinology & metabolism 2025; (39(4)):102022 doi:10.1016/j.beem.2025.102022.

    PMID: 40634221
  6. 6

    Gene Expression in Porcine Bulbourethral Glands.

    Noto V, Nitta-Oda BJ, Berger T

    Animals : an open access journal from MDPI 2024; (14(7)) doi:10.3390/ani14071115.

    PMID: 38612354
  7. 7

    Expression of CSF1, AR, and SRD5A2 during Postnatal Development of the Boar Reproductive Tract.

    Katleba K, Legacki E, Berger T

    Animals : an open access journal from MDPI 2022; (12(17)) doi:10.3390/ani12172167.

    PMID: 36077888
  8. 8

    Androgen insensitivity syndrome.

    Mongan NP, Tadokoro-Cuccaro R, Bunch T, Hughes IA

    Best practice & research. Clinical endocrinology & metabolism 2015; (29(4)):569-80.

    PMID: 26303084
  9. 9

    Complete Androgen Insensitivity Syndrome due to Mutations in the DNA-Binding Domain of the Human Androgen Receptor Gene.

    Chauhan P, Rani A, Singh SK, Rai AK

    Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation 2018; (12(6)):269-274 doi:10.1159/000492261.

    PMID: 30165367
  10. 10

    Somatic mosaicism of androgen receptor gene in an androgen insensitivity syndrome patient conceived through assisted reproduction technique.

    Wang H, Zhu H, Wang N, et al.

    Molecular genetics & genomic medicine 2019; (7(10)):e00906 doi:10.1002/mgg3.906.

    PMID: 31429517
  11. 11

    Complete androgen insensitivity syndrome in a 15-year-old female with primary amenorrhea and undescended testes: a rare case report.

    Zerin F, Bhadra TK, Sadia R, Shahriar Z

    Radiology case reports 2026; (21(1)):329-332 doi:10.1016/j.radcr.2025.09.075.

    PMID: 41209089
  12. 12

    Complete androgen insensitivity syndrome and anti-Müllerian hormone levels before and after laparoscopic gonadectomy.

    Kusumi M, Mitsunami M, Onoue H, et al.

    Gynecology and minimally invasive therapy 2017; (6(3)):126-128 doi:10.1016/j.gmit.2016.11.001.

    PMID: 30254896
  13. 13

    Cell-based assays for screening androgen receptor ligands.

    Campana C, Pezzi V, Rainey WE

    Seminars in reproductive medicine 2015; (33(3)):225-34 doi:10.1055/s-0035-1552989.

    PMID: 26036905
  14. 14

    Novel mutations of the SRD5A2 and AR genes in Thai patients with 46, XY disorders of sex development.

    Ittiwut C, Pratuangdejkul J, Supornsilchai V, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2017; (30(1)):19-26.

    PMID: 27849622
  15. 15

    Targeted Next-Generation Sequencing for the Diagnosis of Gene Variants in Patients with 46,XY Disorder of Sex Development.

    Guo Q, Zhong WW, Lai HJ, et al.

    Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation 2023; (17(1)):26-31 doi:10.1159/000528916.

    PMID: 36689917
  16. 16

    Germ Cell Tumors in 46, XY Gonadal Dysgenesis.

    Misgar RA, Islam Mir SU, Mir MH, et al.

    Indian journal of endocrinology and metabolism 2024; (28(4)):424-428 doi:10.4103/ijem.ijem_373_22.

    PMID: 39371651
  17. 17

    Diagnostic Accuracy of Serum Steroids and Peptides in the Evaluation of 46, XY Disorders of Sex Development (DSD).

    Barnabas R, Lila AR, Memon SS, et al.

    Clinical endocrinology 2025; (103(6)):823-832 doi:10.1111/cen.70017.

    PMID: 40799104
  18. 18

    Molecular Diagnosis of 46,XY Disorders of Sex Development: An Efficient Initial Molecular Analysis Using a Custom-Designed Targeted Gene Panel in a Single-Center Study.

    Poyrazoglu S, Aghayev A, Toksoy G, et al.

    Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation 2026; (20(1-6)):15-25 doi:10.1159/000550371.

    PMID: 41493898
  19. 19

    Contribution of Clinical and Genetic Approaches for Diagnosing 209 Index Cases With 46,XY Differences of Sex Development.

    Gomes NL, Batista RL, Nishi MY, et al.

    The Journal of clinical endocrinology and metabolism 2022; (107(5)):e1797-e1806 doi:10.1210/clinem/dgac064.

    PMID: 35134971
  20. 20

    Rapid Molecular Genetic Diagnosis with Next-Generation Sequencing in 46,XY Disorders of Sex Development Cases: Efficiency and Cost Assessment.

    Özen S, Onay H, Atik T, et al.

    Hormone research in paediatrics 2017; (87(2)):81-87 doi:10.1159/000452995.

    PMID: 27898418
  21. 21

    Molecular genetic diagnosis and surgical management in a cohort of children with 46,XY disorders/differences of sex development.

    Wong YS, Luk HM, Yau HC, et al.

    Frontiers in pediatrics 2025; (13()):1456227 doi:10.3389/fped.2025.1456227.

    PMID: 39936125
  22. 22

    Detection of 46, XY Disorder of Sex Development (DSD) Based on Plasma Cell-Free DNA and Targeted Next-Generation Sequencing.

    De Falco L, Piscopo C, D'Angelo R, et al.

    Genes 2021; (12(12)) doi:10.3390/genes12121890.

    PMID: 34946839
  23. 23

    46, XY under-virilization and NR5A1 variants: Monocentric Indian experience and systematic review.

    Kumar S, Pandit R, Sarathi V, et al.

    Annales d'endocrinologie 2025; (86(4)):101731 doi:10.1016/j.ando.2025.101731.

    PMID: 40280302
  24. 24

    [Genetic analysis of 46,XY disorders of sex development in children caused by a new NR5A1 gene variant].

    Gao L, Wang P, Zhang M, et al.

    Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2021; (38(11)):1123-1126 doi:10.3760/cma.j.cn511374-20200902-00645.

    PMID: 34729757
  25. 25

    Role of the pediatrician in the initial management of a newborn with Differences of Sex Development or hypospadias.

    van der Straaten S, Syryn H, Dessens A, et al.

    European journal of pediatrics 2025; (184(5)):307 doi:10.1007/s00431-025-06140-6.

    PMID: 40261419

This page explains the genetic causes and lab tests associated with 46,XY DSD for educational purposes only. Always consult a genetic counselor or endocrinologist to interpret your specific genetic results and health risks.

Get notified when new evidence is published on 46,XY difference of sex development.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.